Competitive advantage and strategy formulation process

15,804 views

Published on

Published in: Business, Health & Medicine
1 Comment
7 Likes
Statistics
Notes
  • sanofi-aventis is not a Swiss-based company ! It is french !!!
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
No Downloads
Views
Total views
15,804
On SlideShare
0
From Embeds
0
Number of Embeds
134
Actions
Shares
0
Downloads
0
Comments
1
Likes
7
Embeds 0
No embeds

No notes for slide
  • worldwide presence in more than 100 countries throughout the 5 continents
    sales force of 35,000 medical visitors
  • Competitive advantage and strategy formulation process

    1. 1. Competitive advantageCompetitive advantage && Strategy Formulation ProcessStrategy Formulation Process Example: Novartis, Pfizer, Sanofi-Aventis
    2. 2. 12/19/14 2 Table of contentsTable of contents  Competitive advantage –Novartis –Pfizer –Sanofi-Aventis  Strategy formulation process
    3. 3. 12/19/14 3 NovartisNovartis  Merger of Ciba-Geigy and Sandoz  Based in Basel/Switzerland  World leader in providing medicines to protect health,prevent and treat disease, improve well-being  Biggest health care company in Switzerland
    4. 4. 12/19/14 4 Competitive AdvantageCompetitive Advantage  Leadership positions in patented and generic pharmaceuticals  Invest in strategic platforms: – Offer innovative prescription medicine – Cost efficient and qualitative high generics – Vaccines for therapeutical demand of health care – Leading over-the-counter drugs
    5. 5. 12/19/14 5 Pfizer (Comp. Advantage)Pfizer (Comp. Advantage)  Investing in ongoing research, always be the first  Market dominance -> skimming strategy  Acquisition of other pharmaceutical companies  Diversification for both: products and regions  Development of blockbuster products, such as Viagra
    6. 6. 12/19/14 6 Competitive Advantage cont.Competitive Advantage cont.  Taking advantage of lobbyism to get favourable regulations  Unique packaging  Decentralization and de-bureaucratization by splitting its drug research division
    7. 7. 12/19/14 7 Sanofi-AventisSanofi-Aventis  Swiss based company with over 100,000 employees  Merger of Aventis and Sanofi-Synthelabo (2004)  7 major therapeutic areas : Cardiovascular, thrombosis, metabolic disorders, oncology, central nervous system, internal medicine and vaccines
    8. 8. 12/19/14 8 Competitive AdvantageCompetitive Advantage  European leading position  High diversified portfolio of drugs  Largest firm worldwide devoted entirely to vaccines  Advantages in several therapeutic areas – Influenza pandemic – Venous Thrombosis – Cancer healing – Insulin
    9. 9. 12/19/14 9 Strategy formulation process for Novartis
    10. 10. 12/19/14 10 Strategy Formulation ProcessStrategy Formulation Process 4 steps:  Mission: reason for existence  Objectives: what results to be accomplished by when  Strategies: plan to achieve the mission and objectives  Policies: broad guidelines for decision making
    11. 11. 12/19/14 11 MissionMission  Discover, develop and successfully market innovative products  to prevent and cure diseases  to ease suffering  to enhance the quality of life  Providing shareholder return that reflects outstanding performance
    12. 12. 12/19/14 12 Main ObjectivesMain Objectives  Eliminate leprosy by providing free medications to all patients worldwide  Discover noble treatments and prevention methods for major tropical diseases  Work at policy and field level to improve access to healthcare for the world’s poorest people
    13. 13. 12/19/14 13 StrategiesStrategies Strategies Novartis could follow:  Invest in R&D  Promote company in order to get donations  Promote company’s products
    14. 14. 12/19/14 14 PoliciesPolicies  Strive to maintain and strengthen a corporate culture based on: – Integrity – Honesty – Compliance with the law  Strongly commitment to 10 principles of United Nations Global Compact
    15. 15. 12/19/14 15 Corporate CitizenshipCorporate Citizenship  Patients – discover high quality healthcare products  People – build an exciting workplace  Health, Safety and Environment – reduce environmental footprint  Business conduct – ensure corporate governance
    16. 16. Thank you for your attention!Thank you for your attention! Questions???Questions???

    ×